Inactive Ingredient Search for Approved Drug Products
You are Searching: Change and Deletion by Inactive Ingredient Name Beginning with E
| Quarter | Inactive Ingredient | Route of Administration | Dosage Form | Maximum Potency per unit dose | Maximum Daily Exposure | Status | |
|---|---|---|---|---|---|---|---|
| Q2 2024 | ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW) | ORAL | CAPSULE | 116.89 mg | 135mg | Deletion | |
| Q1 2024 | EDETATE DISODIUM | OPHTHALMIC | SUSPENSION/ DROPS | 0.10 %w/v | MDE Replacement | ||
| Q2 2024 | EDETATE DISODIUM | OPHTHALMIC | SUSPENSION/ DROPS | 1mg | MDE Replacement | ||
| Q1 2024 | ETHYLCELLULOSE AQUEOUS DISPERSION TYPE A | ORAL | TABLET | 12.75 mg | MDE Replacement | ||
| Q2 2024 | ETHYLCELLULOSE AQUEOUS DISPERSION TYPE A | ORAL | TABLET | 23mg | MDE Replacement |
FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections: IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly
Data Through: March 15, 2024
Database Last Updated: April 29, 2024